Assignee
SHANGHAI YINGLI PHARM CO LTD
CN·10 granted patents·5 pending applications·2 citations·filing 2013–2024
Top patents by PatentIndex Score
15 records- 0169US9656996B2Fused heterocyclic compound, preparation method therefor, pharmaceutical composition, and uses thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2014·Granted May 23, 2017·2 cites·15 claims
- 0262US2025154142A1Thiadiazole-substituted compound, pharmaceutical compositions thereof, and applications thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2024·Application pending·0 cites
- 0359US2025059202A1Crystal form of fused ring derivative, and preparation method therefor and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2022·Application pending·0 cites
- 0458US11168072B2Crystal form of morpholino quinazoline compound, preparation method therefor and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2019·Granted Nov 9, 2021·0 cites·10 claims
- 0558US2025042891A1Compound containing structure of a heteroaromatic ring, pharmaceutical composition thereof and application thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0656US10100016B2Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2018·Granted Oct 16, 2018·0 cites·16 claims
- 0755US2024217947A1Morpholinylquinazoline Compound, Pharmaceutical compositions thereof and Use ThereofSHANGHAI YINGLI PHARM CO LTD·Filed 2022·Application pending·0 cites
- 0854US11505542B2Preparation method for morpholinquinazoline compound and intermediates thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2019·Granted Nov 22, 2022·0 cites·20 claims
- 0951US10100015B2Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2016·Granted Oct 16, 2018·0 cites·16 claims
- 1045US2022315598A1Oxygen-containing Heterocyclic Compound, Preparation Method Therefor and Use ThereofSHANGHAI YINGLI PHARM CO LTD·Filed 2020·Application pending·0 cites
- 1143US9745321B2Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2014·Granted Aug 29, 2017·0 cites·45 claims
- 1240US11584745B2Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2018·Granted Feb 21, 2023·0 cites·16 claims
- 1339US11447490B2Aromatic heterocyclic substituted olefin compound, preparation method for same, pharmaceutical composition of same, and applications thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2018·Granted Sep 20, 2022·0 cites·14 claims
- 1439US9738603B2Complex of glucose derivative and proline, crystal, preparation method and useSHANGHAI YINGLI PHARM CO LTD·Filed 2013·Granted Aug 22, 2017·0 cites·11 claims
- 1537US11466003B2Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2017·Granted Oct 11, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI YINGLI PHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →